p53 alterations and their relationship to SDHD mutations in parasympathetic paragangliomas

Keyphrases

• Paraganglioma 100%
• Tumor 60%
• Murine Double Minute 2 (MDM2) 60%
• Tumorigenesis 60%
• Clinical Data 40%
• Cell Cycle Arrest 40%
• Apoptosis 40%
• Hypoxia 40%
• P53 Expression 40%
• P53 Inactivation 40%
• Exon 5 40%
• P53 Pathway 20%
• Aberrations 20%
• TP53 mutation 20%
• Germ Cells 20%
• Germline mutation 20%
• Overexpression 20%
• Immunohistochemistry 20%
• Protein Expression 20%
• Expression Data 20%
• Gene mutation 20%
• Enzyme Complex 20%
• Inducer 20%
• Paraganglia 20%
• P53 Protein 20%
• PCR-SSCP 20%
• Succinate Dehydrogenase 20%
• Inactivating mutation 20%
• Succinate Dehydrogenase Subunit B 20%
• Dehydrogenase Enzyme 20%
• Hereditary Paraganglioma 20%
• Observational Evidence 20%
• MDM2 Protein 20%
• Hypoxic Stimulus 20%

Neuroscience

• P53 100%
• Carcinogenesis 23%
• Exon 15%
• Cell Cycle Checkpoint 15%
• Cell Cycle Arrest 15%
• Germ Cell 15%
• Succinate Dehydrogenase 15%
• Fumarate Reductase 15%
• Protein Expression 7%
• Immunohistochemistry 7%
• Gene Mutation 7%
• Protein MDM2 7%